Krebs – zum Fürchten!?

Zusammenfassung

Psychosoziale und psychoonkologische Aspekte finden mittlerweile im Rahmen einer ganzheitlichen Behandlung von Tumor-Patienten, welche körperliche, psychische und soziale Faktoren im Sinne des bio-psychosozialen Verständnisses gleichgewichtig einbezieht, zunehmend Beachtung.

Dieser Beitrag gibt einen Überblick über die psychische Belastung sowie Verteilung von subsyndromalen und Störungsbildern bei Krebs-Patienten mit dem Schwerpunkt Progressionsangst und gibt anhand von Fallvignetten exemplarisch Einblick in häufig thematisierte Probleme im Umgang mit Angst.

Summary

During the last years, psychosocial and psycho-oncological aspects received increased attention in the framework of the bio-psycho-social model of tumor patients’ treatment. This article presents a short introducing overview about psychological distress, fear of cancer recurrence and disorders in patients treated for cancer. Using exemplary patients, typical topics of the different illnessand treatment phase will be illustrated.

Schlüsselwörter

Psychische Belastung - Progredienzangst - S3-Leitlinie

Keywords

Distress - anxiety - fear of cancer recurrence - psycho-oncology - S3-guideline

• Literatur

• 1 Aghababei N, Sohrabi F, Eskandarie H, Borjali A, Farrokhi N, Chen ZJ. Predicting subjective wellbeing by religous and scientific attitudes with hope, proprose in life, and death anxiety as mediators. Personality and Individual Differences 2016; 90: 93-98.
• 2 Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion MJM, Holland JC. et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology Guideline Adaption. Journal of Clinical Oncology 2014; 32 (15) 1605-1619.
• 3 Blázquez MH, Cruzado JA. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy. Journal of Psychosomatic Research 2016; 87: 14-21.
• 4 Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncology 2013; 22: 978-986.
• 5 Dehne M. Soziologie der Angst. Wiesbaden: Springer; 2017. DOI: 10.1007/978–3– 658–15223–0_1.
• 6 Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology 2013; 31 (06) 782-93.
• 7 Faller H, Bähler E, Härter M, Keller M, Schulz H, Wegschneider K. et al. Unmet needs for information and psychosocial support in relation to quality of life and emotional distress: A comparison between gynecological and breast cancer patients. Patient Education and Counseling. http://dx.doi.org/10.1016/j.pec2017.05.031
• 8 Faller H, Weis J, Koch U, Brähler E, Härter M, Keller M. et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. Journal of Psychosomatic Research 2016; 81: 24-30.
• 9 Fried E. Gegengift. 49 Gedichte und ein Zyklus. Wagenbach. 1974
• 10 Garcia S. The effect of patient education on Aaapy for the first time. Evidence-based practice project reports 2014; Paper 47.
• 11 Graske MG, Stein MB. Anexiety. Lancet 2016; 388: 3048-59.
• 12 Hartung TJ, Friedrich M, Johansen Ch, Wittchen H-U, Faller H, Koch U. et al. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as Screening Instruments for Depression in Patients With Cancer. DOI:10.1002/cncr.30846.
• 13 Herschbach P, Dinkel A. Psychologische Interventionen bei Progredienzangst. In: Mehnert A, Koch U. (Hrsg) Handbuch Psychoonkologie. Göttingen: Hogrefe; 2016: 618-624.
• 14 Herschbach P, Dinkel A. Angst bei körperlichen Erkrankungen PiD – Psychotherapie im. Dialog 2015; 16 (02) 60-62.
• 15 Herschbach P, Dinkel A. Fear of progression. Psycho-Oncology. 2014: 197 DOI: 10.1007/ 978–3–642–40187–9_2.
• 16 Höcker A, Krüll A, Koch U, Mehnert A. Exploring spiritual needs and their associated factors in an urban sample of early and advanced cancer patients. Eur J Cancer Care. 2014. DOI: 10.1111/ ecc.12200.
• 17 Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors – a systematic review of quantitative studies. Psycho-Oncology 2013; 22 1-11.
• 18 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten. AWMF. 2014
• 19 Lewis F, Merckaert I, Liénard A, Libert Y, Etienne AM, Reynaert C. et al. Anxiety at the first radiotherapy session for non-metastatic breast cancer: Key communication and communication-related predictors. Radiotherapy and Oncology 2014; 114: 35-41.
• 20 Lin CR, Chen SC, Chang JTC, Fang YY, Lai YH. Fear of cancer recurrence and its impacts on quality of life in family caregivers of patients with head and neck cancers. The Journal of Nursing Research 2016; 24 (03) 240-248.
• 21 McDonnell G, Baily C, Schuler T, Verdeli H. Anxiety among adolescent survivors of pediatric cancer: A missing link in the survivorship literature. Palliative and Supportive Care 2015; 13: 345-349.
• 22 Mehnert A. Psychoonkologische Mitbetreuung und Nachsorge Identifikation, Unterstützungsangebote und Umgang mit den Krankheitsfolgen. Klinikarzt 2014; 43 (7+8): 364-367.
• 23 Mehnert A. et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology 2014; 32 (31) 3540-3546.
• 24 Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2006; 54 (03) 213-223.
• 25 Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C. et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncology 2011; 12 (02) 160-74.
• 26 Mitchell AJ. et al. Depression and anxiety in longterm cancer survivors compared with spouses and healthy controls: a systematic review and metaanalysis. Lancet Oncol 2013; 14 (08) 721-32.
• 27 Moncayo FLG, Requena GC, Perez FJ, Salamero M, Sanchez N, Sirgo A. Psychological adjustment and prevalence of psychiatric disorders in cancer patients. Med Clin (Barc) 2008; 130 (03) 90-2.
• 28 Morgan S, Cooper B, Paul S, Hammer MJ, Conley YP. et al. Asscociation of personality profiles with depressive, anxiety, and cancer-related symptoms in patients undergoing chemotherapy. Personality and Individual Differences 2017; 117: 130-138.
• 29 Rudolf B, Wünsch A, Herschbach P, Dinkel A. Ambulante verhaltenstherapeutische Gruppentherapie zur Behandlung von Progredienzangst bei Krebspatienten. Psychother Psych Med. DOI: htpp://dx.doi.org/10.1055/s-0043–107774.
• 30 Scheffold K, Philipp R, Koranyi S, Engelmann D, Schulz-Kindermann F, Mehnert A. Insecure attachment predicts depression and death anxiety in advanced cancer patients. Palliative and Supportive Care. 2017; 1-9 DOI: 10.1017/ S147895157000281.
• 31 Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care – A meta-analysis. Psychooncology 2010; 19 Supplement: 134-5.
• 32 Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J. et al. Comorbid mental health conditions in cancer patients at working age – prevalence, risk profiles, and care uptake. Psychooncology 2013; 22: 2291-7.
• 33 Stiefel F. Umgang mit Angst – Gespräch mit Kranken. Im Fokus Onkologie 2004; 10: 47-49.
• 34 Vehling S, Koch U, Ladehoff N, Schön G, Wegscheider K, Heckl U. et al. Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse. Psychotherapie Psychosomatik Medizinische Psychologie 2012; 62: 249-58.